EDRH
VKTX icon

Edmond de Rothschild Holding’s Viking Therapeutics VKTX Stock Holding History

Edmond de Rothschild Holding’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.5K Hold
1,000
– – ﹤0.01% 468
2025
Q4 		$35.2K Hold
1,000
– – ﹤0.01% 481
2025
Q3 		$26.3K Hold
1,000
– – ﹤0.01% 500
2025
Q2 		$26.5K Hold
1,000
– – ﹤0.01% 492
2025
Q1 		$24.1K Buy
1,000
+500
+100% +$15.8K ﹤0.01% 504
2024
Q4 		$20.1K Hold
500
– – ﹤0.01% 548
2024
Q3 		$31.7K Hold
500
– – ﹤0.01% 558
2024
Q2 		$26.5K Buy
+500
New +$32.8K ﹤0.01% 599

Other funds holding VKTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Edmond de Rothschild Holding's VKTX Position: Q1 2026 in Review

Edmond de Rothschild Holding held its Viking Therapeutics (VKTX) position steady in Q1 2026 at 1,000 shares worth $32.5K. The position accounts for ﹤0.01% of the portfolio, ranked #468.

Edmond de Rothschild Holding first reported a position in VKTX in Q2 2024 and has held it in 8 quarters since. The position peaked at $35.2K in Q4 2025. 410 funds tracked by Wall St. Rank hold VKTX as of Q1 2026.

  • Edmond de Rothschild Holding held 1,000 shares of Viking Therapeutics worth $32.5K as of Q1 2026.
  • Edmond de Rothschild Holding left its Viking Therapeutics share count unchanged in Q1 2026.
  • Viking Therapeutics made up ﹤0.01% of Edmond de Rothschild Holding's portfolio in Q1 2026, its #468 holding.
  • Edmond de Rothschild Holding first reported a position in Viking Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Edmond de Rothschild Holding's Viking Therapeutics position peaked at $35.2K in Q4 2025.
  • 410 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2026.

Based on Edmond de Rothschild Holding's 13F filing for Q1 2026, filed 13 May 2026.